Retraction
Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis
Paper Information
Record ID:
25510
Author(s):
Journal:
Publication Date:
July 24, 2020
Retraction Date:
January 22, 2021
(4.8 years years ago)
Subjects:
Institutions:
- West China Hospital, China
- Neurosurgical Clinical Research Center of Sichuan Province, China
- Soochow University, Soochow, China
- Department of Neurosurgery, Affiliated Hospital of Southwest Medical University, Luzhou, China
- Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations0
Post-Retraction2
Pre-Retraction1
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis: Retraction
Unknown Authors
Medicine
Open Access
Published: Jan 2021
Same day as retraction
CD44 as a tumor biomarker and therapeutic target
Hanxiao Xu, Mengke Niu, Xun Yuan et al. (5 authors)
Experimental Hematology and Oncology
Open Access
Published: Dec 2020
275 citations
275 citations
52 days before retraction
Expression of POU2F3 Transcription Factor Control Inflammation, Immunological Recruitment and Metastasis of Pancreatic Cancer in Mice
Jennifer Bintz, Analía Meilerman Abuelafia, François Gerbe et al. (8 authors)
Biology
Open Access
Published: Oct 2020
11 citations
11 citations
95 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
4.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025